2. Goldstraw P, Chansky K, Crowley J, et al. The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer. J Thorac Oncol 2016;11:39-51.
3. Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Ann Thorac Surg 1995;60:615-22.
4. Bao F, Ye P, Yang Y, et al. Segmentectomy or lobectomy for early stage lung cancer: a meta-analysis. Eur J Cardio-thoracic Surg 2014;46:1-7.
5. Dziedzic R, Zurek W, Marjański T, et al. Stage I non-small-cell lung cancer: long-term results of lobectomy versus sublobar resection from the polish national lung cancer registry. Eur J Cardio-thoracic Surg 2017;52:363-9.
6. Song CY, Sakai T, Kimura D, Tsushima T, Fukuda I. Comparison of perioperative and oncological outcomes between video-assisted segmentectomy and lobectomy for patients with clinical stage IA non-small cell lung cancer: a propensity score matching study. J Thorac Dis 2018;10:4891-901.
7. Cao J, Yuan P, Wang Y, et al. Survival rates after lobectomy, segmentectomy, and wedge resection for non-small cell lung cancer. Ann Thorac Surg 2018;105:1483-91.
8. Moon MH, Moon YK, Moon SW. Segmentectomy versus lobectomy in early non-small cell lung cancer of 2 cm or less in size: a population-based study. Respirology 2018;23:695-703.
9. Ackerson BG, Tong BC, Hong JC, et al. Stereotactic body radiation therapy versus sublobar resection for stage I NSCLC. Lung Cancer 2018;125:185-91.
10. Hiraki T, Gobara H, Mimura H, Matsui Y, Toyooka S, Kanazawa S. Percutaneous radiofrequency ablation of clinical stage I non-small cell lung cancer. J Thorac Cardiovasc Surg 2011;142:24-30.
11. Nagata Y, Hiraoka M, Shibata T, et al. Prospective trial of stereotactic body radiation therapy for both operable and inoperable T1N0M0 non-small cell lung cancer: Japan Clinical Oncology Group Study JCOG0403. Int J Radiat Oncol Biol Phys 2015;93:989-96.
12. Tandberg DJ, Tong BC, Ackerson BG, Kelsey CR. Surgery versus stereotactic body radiation therapy for stage I non-small cell lung cancer: a comprehensive review. Cancer 2018;124:667-78.
13. Nyman J, Hallqvist A, Lund JÅ, et al. SPACE - a randomized study of SBRT vs conventional fractionated radiotherapy in medically inoperable stage I NSCLC. Radiother Oncol 2016;121:1-8.
14. Li C, Wang L, Wu Q, et al. A meta-analysis comparing stereotactic body radiotherapy vs conventional radiotherapy in inoperable stage I non-small cell lung cancer. Medicine (Baltimore) 2020;99:e21715.
15. Falkson CB, Vella ET, Yu E, et al. Radiotherapy with curative intent in patients with early-stage, medically inoperable, non-small-cell lung cancer: a systematic review. Clin Lung Cancer 2017;18:105-21.e5.
16. Varlotto J, Fakiris A, Flickinger J, et al. Matched-pair and propensity score comparisons of outcomes of patients with clinical stage i non-small cell lung cancer treated with resection or stereotactic radiosurgery. Cancer 2013;119:2683-91.
17. Timmerman RD, Paulus R, Galvin J, et al. Stereotactic body radiation therapy for medically inoperable early-stage lung cancer patients. JAMA 2010;303:1070-6.
18. Harris AA, Stang K, Small C, et al. Pretreatment factors influencing radiation pneumonitis after stereotactic body radiation therapy in the treatment of lung cancer. Cureus 2020;12.
19. Morias S, Marcu LG, Short M, et al. Treatment-related adverse effects in lung cancer patients after stereotactic ablative radiation therapy. J Oncol 2018;2018:6483626.
20. Wink KCJ, van Baardwijk A, Troost EGC, De Ruysscher D. Nodal recurrence after stereotactic body radiotherapy for early stage non-small cell lung cancer: incidence and proposed risk factors. Cancer Treat Rev 2017;56:8-15.
21. Altorki NK, Kamel MK, Narula N, et al. Anatomical segmentectomy and wedge resections are associated with comparable outcomes for patients with small cT1N0 non-small cell lung cancer. J Thorac Oncol 2016;11:1984-92.
22. Gossot D, Lutz J, Grigoroiu M, Brian E, Seguin-Givelet A. Thoracoscopic anatomic segmentectomies for lung cancer: technical aspects. J Vis Surg 2016;2:171.
23. Guo Z, Yin W, Pan H, et al. Video-assisted thoracoscopic surgery segmentectomy by non- intubated or intubated anesthesia : a comparative analysis of short-term outcome. J Thorac Dis 2016;8:359-68.
24. Hung MH, Hsu HH, Chan KC, et al. Non-intubated thoracoscopic surgery using internal intercostal nerve block, vagal block and targeted sedation. Eur J Cardiothorac Surg 2014;46:620-5.
25. Charloux A, Quoix E. Lung segmentectomy: does it offer a real functional benefit over lobectomy? Eur Respir Rev 2017;26:170079.
26. Traibi A, Grigoroiu M, Boulitrop C, et al. Predictive factors for complications of anatomical pulmonary segmentectomies. Interact Cardiovasc Thorac Surg 2013;17:838-44.
28. Vansteenkiste J, Crino L, Dooms C, et al. 2nd ESMO consensus conference on lung cancer: early stage non-small cell lung cancer consensus on diagnosis, treatment and follow-up. Ann Oncol 2014;25:1462-74.
29. Nakamura K, Saji H, Nakajima R, et al. A phase III randomized trial of lobectomy versus limited resection for small-sized peripheral non-small cell lung cancer (JCOG0802/WJOG4607L). Jpn J Clin Oncol 2009;40:271-4.
30. Linden D, Linden K, Oparka J. In patients with resectable non-small-cell lung cancer, is video-assisted thoracoscopic segmentectomy a suitable alternative to thoracotomy and segmentectomy in terms of morbidity and equivalence of resection? Interact Cardiovasc Thorac Surg 2014;19:107-10.
31. Linden D, Linden K, Oparka J. In patients with resectable non-small-cell lung cancer, is video-assisted thoracoscopic segmentectomy a suitable alternative to thoracotomy and segmentectomy in terms of morbidity and equivalence of resection? Interact Cardiovasc Thorac Surg 2014;19:107-10.
32. Ohtaki Y, Shimizu K. Anatomical thoracoscopic segmentectomy for lung cancer. Gen Thorac Cardiovasc Surg 2014;62:586-93.
33. Veronesi G. Robotic lobectomy and segmentectomy for lung cancer: results and operating technique. J Thorac Dis 2015;7:S122-30.
34. Schneider BJ, Daly ME, Kennedy EB, Stiles BM. Stereotactic body radiotherapy for early-stage non?small-cell lung cancer: American society of clinical oncology endorsement of the American society for radiation oncology evidence-based guideline summary. J Oncol Pract 2018;14:180.
35. Tamura M, Matsumoto I, Tanaka Y, et al. Comparison between stereotactic radiotherapy and sublobar resection for non-small cell lung cancer. Ann Thorac Surg 2019;107:1544-50.
36. Yendamuri S, Komaki RR, Correa AM, et al. Comparison of limited surgery and three-dimensional conformal radiation in high-risk patients with stage I non-small cell lung cancer. J Thorac Oncol 2007;2:1022-8.
37. Puri V, Crabtree T, Kymes S, et al. A comparison of surgical intervention and stereotactic body radiation therapy for stage i lung cancer in high-risk patients: a decision analysis. J Thorac Cardiovasc Surg 2012;143:428-36.
38. Grills IS, Mangona V, Welsh R, et al. Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer (NSCLC). J Clin Oncol 2010;28:928-35.
39. Forquer J, McGarry R, Kesler K, et al. A matched-pair analysis of sublobar resection and stereotactic body radiotherapy (SBRT) for stage I NSCLC. Int J Radiat Oncol Biol Phys 2007;69:S492-3.
40. Matsuo Y, Chen F, Hamaji M, et al. Comparison of long-term survival outcomes between stereotactic body radiotherapy and sublobar resection for stage i non-small-cell lung cancer in patients at high risk for lobectomy: a propensity score matching analysis. Eur J Cancer 2014;50:2932-8.
41. Fernando HC, Timmerman RD. American College of Surgeons Oncology Group Z4099/Radiation Therapy Oncology Group 1021: a randomized study of sublobar resection compared with stereotactic body radiotherapy for high-risk stage I non-small cell lung cancer. J Thorac Cardiovasc Surg 2012;144:S35-8.
42. Mahmood S, Bilal H, Faivre-Finn C, Shah R. Is stereotactic ablative radiotherapy equivalent to sublobar resection in high-risk surgical patients with Stage I non-small-cell lung cancer? Interact Cardiovasc Thorac Surg 2013;17:845-53.
43. Scanagatta P. Is surgery still worthwhile as compared to stereotactic ablative radiotherapy or CyberKnife in high-risk surgical patients with stage I non-small-celllung cancer? E-comment. Interact Cardiovasc Thorac Surg 2013;17:853.
44. Snee MP, McParland L, Collinson F, et al. The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I non. Pilot Feasibility Stud 2016;2:5.
45. Ettinger DS, Wood DE, Aisner DL, et al. Non-Small cell lung - NCCN clinical practice guidelines in oncology, v1. 2021.
46. Onishi H, Shirato H, Nagata Y, et al. Stereotactic body radiotherapy (SBRT) for operable stage I non-small-cell lung cancer: can SBRT be comparable to surgery? Int J Radiat Oncol Biol Phys 2011;81:1352-8.
47. Deng HY, Wang YC, Ni PZ, et al. Radiotherapy, lobectomy or sublobar resection? A meta-analysis of the choices for treating stage I non-small-cell lung cancer. Eur J Cardio-thoracic Surg 2017;51:203-10.
48. Chen H, Laba JM, Boldt RG, et al. Stereotactic ablative radiation therapy versus surgery in early lung cancer: a meta-analysis of propensity score studies. Int J Radiat Oncol Biol Phys 2018;101:186-94.
49. Iguchi T, Hiraki T, Matsui Y, et al. Survival outcomes of treatment with radiofrequency ablation, stereotactic body radiotherapy, or sublobar resection for patients with clinical stage I non-small-cell lung cancer: a single-center evaluation. J Vasc Interv Radiol 2020;31:1044-51.
50. Bryant AK, Mundt RC, Sandhu AP, et al. Stereotactic body radiation therapy versus surgery for early lung cancer among US veterans. Ann Thorac Surg 2018;105:425-31.
51. Wu J, Bai HX, Chan L, et al. Sublobar resection compared with stereotactic body radiation therapy and ablation for early stage non-small cell lung cancer: a national cancer database study. J Thorac Cardiovasc Surg 2020;160:1350-7.e11.
52. Videtic GM, Donington J, Giuliani M, et al. Stereotactic body radiation therapy for early stage non-small cell lung cancer: executive summary of an ASTRO evidence-based guideline. Pract Radiat Oncol 2017;7:295-301.
53. Gierada D, Pinsky P. Survival after detection of stage I lung cancer by screening in the national lung screening trial. Chest 2020;3:34234-5.
54. Horeweg N, Scholten ET, de Jong PA, et al. Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers. Lancet Oncol 2014;15:1342-50.
55. Senan S, Paul MA, Lagerwaard FJ. Treatment of early-stage lung cancer detected by screening: surgery or stereotactic ablative radiotherapy? Lancet Oncol 2013;14:e270-4.
56. Swensen S, Silverstein M, Ilstrup D, et al. The probability of malignancy in solitary pulmonary nodules: application to small radiologically indeterminate nodules. Arch Intern Med 1997;157:849-55.
57. Palma D, Lagerwaard F, Rodrigues G, Haasbeek C, Senan S. Curative treatment of Stage i non-small-cell lung cancer in patients with severe COPD: stereotactic radiotherapy outcomes and systematic review. Int J Radiat Oncol Biol Phys 2012;82:1149-56.
Comments
Comments must be written in English. Spam, offensive content, impersonation, and private information will not be permitted. If any comment is reported and identified as inappropriate content by OAE staff, the comment will be removed without notice. If you have any queries or need any help, please contact us at support@oaepublish.com.